Bioequivalence and pharmacokinetic comparison between extended release capsules of carvedilol phosphate 40 mg: An open label, balanced, randomized-sequence, single-dose, two-period crossover study in healthy male volunte
phenyl carvedilol concentrations was performed using a validated LC-MS/MS method. The pharmacokinetic parameters were analyzed using the non-compartmental model. Drug safety and tolerability were assessed. The primary

